<DOC>
	<DOCNO>NCT02786654</DOCNO>
	<brief_summary>The aim study investigate association use β blocker mortality among hospital survivor acute myocardial infarction without heart failure .</brief_summary>
	<brief_title>β Blocker Use Mortality Hospital Survivors Acute Myocardial Infarction Without Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<criteria>acute myocardial infarction patient age 18 100 year final diagnosis besides acute myocardial infarction die inhospital patient miss mortality data age &gt; 100 patient previous acute myocardial infarction angina patient receive coronary intervention patient heart failure patient β blocker prior use patient contraindicate β blocker use patient use loop diuretic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Acute myocardial infarction</keyword>
	<keyword>mortality</keyword>
	<keyword>evidence-based care</keyword>
	<keyword>Myocardial Ischaemia National Audit Project</keyword>
	<keyword>β blocker</keyword>
</DOC>